Fig. 2.
Decision curve analysis of the genomic urine assay (red line) versus current best practice (cystoscopy in all patients, gray line). The net benefit risk threshold is 0.027, which corresponds to a cost-to-benefit ratio of 1:36.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.